Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
BPC-157 is an investigational synthetic peptide that has not been approved by the FDA for any use
resistant to enzymatic breakdown Studied applications Cell migration and signalling pathway research Angiogenesis pathway research VEGFR2 receptor studies Collagen and matrix pathway research in preclinical models Comparative research against combination formulations Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included COA shown in the product gallery cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Storage & handling Store lyophilized vials refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water
Signs of Pain: Look for subtle signs like reluctance to move, a hunched posture, or sensitivity when being picked up
They are often prescribed to patients with obesity and/or Type 2 diabetes
Patients with certain genetic markers may respond faster to semaglutide or benefit from different dosing schedules
safety disclaimers are clear on the website
